Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Asher Bio has raised $55.0M in total funding. The most recent round was Series C. The last funding was announced in April 2024.
Asher Bio's investors include Y Combinator, Wellington Management, AstraZeneca, RA Capital Management, Third Rock Ventures.
Asher Bio is headquartered in San Francisco, United States.
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Asher Bio is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asher Bio — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/asher-bio. Accessed October 29, 2026.
VCBacked. (2024). Asher Bio — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/asher-bio
{{cite web |title=Asher Bio — Funding & Investors |url=https://www.vcbacked.co/company/asher-bio |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated